Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.…
Haoxi Health Technology (NASDAQ: HAO) is listed on Nasdaq, where its shares trade in USD. It belongs to the Advertising Agencies industry, part of the Communication Services sector, and reports about 28 employees.
The shares were at 1.600 USD on 20 November 2026, down 98.7% over 52 weeks. Its 52-week range is 0.1400 USD to 217.60 USD: the price is 99.3% below the high and 1042.9% above the low.
Its market capitalisation is 1.02M USD.
Haoxi Health Technology reports return on equity of -53.4%, an operating margin of -14.9% and revenue up 137.3% year over year.
It holds more cash than debt, a net cash position of 9.32M USD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.